Polaryx Therapeutics Inc (PLYX)

$2.21 +0.02 (0.91%)
Market Cap 115.14M
Revenue (ttm) 0.00
Net Income (ttm) -8.99M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 42,620
Avg Vol 194,660
Day's Range N/A - N/A
Shares Out 49.85M
Stochastic %K 62%
Beta N/A
Analysts Strong Sell
Price Target $8.50

Company Profile

Polaryx Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of disease-modifying therapies for rare and pediatric lysosomal storage disorders in the United States. Its pipeline includes PLX-100, a preclinical stage orally administrable combination therapy; PLX-200, a repurposed oral small molecule for the treatment of LSDs; PLX-300, a preclinical stage orally administrable combination therapy; and PLX-400, a preclinical stage n...

Industry: Biotechnology
Sector: Healthcare
Phone: 201 940 7236
Website: polaryx.com
Address:
South Tower, 140 E Ridgewood Avenue Suite 415, Paramus, United States
Paraplego
Paraplego Aug. 4 at 3:52 PM
$NWBO is waiting game and im fine with it while im waiting im investing in $PLYX 14th Avgust is close for News and some small gains
0 · Reply
lew0303
lew0303 Jul. 31 at 1:47 PM
$PLYX still going up?
0 · Reply
z____b1
z____b1 Jul. 31 at 1:18 PM
$PLYX Not Bad!
0 · Reply
Bkaytradez
Bkaytradez Jul. 31 at 8:28 AM
$PLYX sub 2$ entry already paying off 💰
0 · Reply
Bkaytradez
Bkaytradez Jul. 31 at 8:28 AM
$PLYX 👀
0 · Reply
Lowkeyoptions
Lowkeyoptions Jul. 30 at 8:53 PM
$PLYX offering closed on watch
0 · Reply
Yebego
Yebego Jul. 29 at 6:18 PM
$AMIX $GSUN $NCRA $PLYX $SPRC
0 · Reply
HustlerTV
HustlerTV Jul. 29 at 6:09 PM
$PLYX short squeeze incoming $20 fair value… $NCRA $GSUN $SPRC $AMIX on watch for power hour
0 · Reply
StockfatherOG
StockfatherOG Jul. 29 at 6:08 PM
$PLYX golden biotech opportunity. Multiple $7 Price targets.
0 · Reply
Deelam
Deelam Jul. 28 at 3:34 AM
$PLYX Another initial coverage setting the PT at $7. https://uk.investing.com/news/stock-market-news/lucid-capital-initiates-polaryx-stock-with-buy-rating-on-rare-disease-therapy-potential-93CH-4789487
0 · Reply
Latest News on PLYX
Polaryx Therapeutics Proxy statement: Proxy filing

Jul 28, 2026, 8:00 AM EDT - 7 days ago

Polaryx Therapeutics Proxy statement: Proxy filing

Polaryx Therapeutics Proxy statement: Proxy filing

Jul 28, 2026, 8:00 AM EDT - 7 days ago

Polaryx Therapeutics Proxy statement: Proxy filing

Polaryx initiated with a Buy at Lucid Capital

2026-07-27T10:45:35.000Z - 8 days ago

Polaryx initiated with a Buy at Lucid Capital

Polaryx Therapeutics Slides: Company presentation

Jul 23, 2026, 8:00 AM EDT - 12 days ago

Polaryx Therapeutics Slides: Company presentation

Polaryx initiated with a Buy at H.C. Wainwright

2026-07-09T10:15:08.000Z - 26 days ago

Polaryx initiated with a Buy at H.C. Wainwright

Polaryx Therapeutics Announces Closing of $10 Million Private Placement Equity Financing to Support Launch of SOTERIA Phase 2 Basket Trial

May 28, 2026, 8:30 AM EDT - 2 months ago

Polaryx Therapeutics Announces Closing of $10 Million Private Placement Equity Financing to Support Launch of SOTERIA Phase 2 Basket Trial

Polaryx Therapeutics Quarterly report: Q1 2026

May 15, 2026, 7:00 AM EDT - 2 months ago

Polaryx Therapeutics Quarterly report: Q1 2026

Polaryx Therapeutics Receives GHP Magazine's Healthcare & Pharmaceuticals Awards

May 14, 2026, 9:15 AM EDT - 2 months ago

Polaryx Therapeutics Receives GHP Magazine's Healthcare & Pharmaceuticals Awards

Polaryx Therapeutics Slides: Corporate presentation

May 8, 2026, 7:00 AM EDT - 3 months ago

Polaryx Therapeutics Slides: Corporate presentation

Polaryx Therapeutics to Participate in National Tay-Sachs & Allied Diseases Association Annual Family Conference

Apr 23, 2026, 8:30 AM EDT - 3 months ago

Polaryx Therapeutics to Participate in National Tay-Sachs & Allied Diseases Association Annual Family Conference

Polaryx receives U.S. FDA Fast Track Designation for PLX-200

2026-04-21T12:59:55.000Z - 3 months ago

Polaryx receives U.S. FDA Fast Track Designation for PLX-200

Polaryx Therapeutics Receives U.S. FDA Fast Track Designations for All Four Indications to be Evaluated in the SOTERIA Basket Trial

Apr 21, 2026, 8:30 AM EDT - 3 months ago

Polaryx Therapeutics Receives U.S. FDA Fast Track Designations for All Four Indications to be Evaluated in the SOTERIA Basket Trial

Polaryx Therapeutics Recognized with Pinnacle Award for Excellence in Pediatric Care

Apr 15, 2026, 9:15 AM EDT - 3 months ago

Polaryx Therapeutics Recognized with Pinnacle Award for Excellence in Pediatric Care

Polaryx Therapeutics To Participate In The 25th Annual Needham Virtual Healthcare Conference

Apr 1, 2026, 8:30 AM EDT - 4 months ago

Polaryx Therapeutics To Participate In The 25th Annual Needham Virtual Healthcare Conference

Polaryx Therapeutics Annual report: Q4 2025

Mar 24, 2026, 8:00 AM EDT - 4 months ago

Polaryx Therapeutics Annual report: Q4 2025

Polaryx’s PLX-200 granted FDA Fast Track Designation in LINCL/CLN2

2026-03-17T12:51:50.000Z - 5 months ago

Polaryx’s PLX-200 granted FDA Fast Track Designation in LINCL/CLN2

Polaryx Therapeutics Receives FDA Fast Track Designation for PLX‑200 for Late‑Infantile Neuronal Ceroid Lipofuscinosis (CLN2 Disease)

Mar 17, 2026, 8:30 AM EDT - 5 months ago

Polaryx Therapeutics Receives FDA Fast Track Designation for PLX‑200 for Late‑Infantile Neuronal Ceroid Lipofuscinosis (CLN2 Disease)

Polaryx Therapeutics, Inc trading resumes

2026-03-12T15:10:39.000Z - 5 months ago

Polaryx Therapeutics, Inc trading resumes

Polaryx Therapeutics, Inc trading halted, volatility trading pause

2026-03-12T15:05:41.000Z - 5 months ago

Polaryx Therapeutics, Inc trading halted, volatility trading pause

Polaryx Therapeutics Deepens Engagement with the Krabbe Disease Community Through Scientific and Patient Advocacy Events

Mar 12, 2026, 8:30 AM EDT - 5 months ago

Polaryx Therapeutics Deepens Engagement with the Krabbe Disease Community Through Scientific and Patient Advocacy Events

Polaryx Therapeutics Slides: Corporate presentation

Mar 6, 2026, 6:00 AM EST - 5 months ago

Polaryx Therapeutics Slides: Corporate presentation

Maxim starts Polaryx at Buy, sees PLX-200 as differentiated

2026-02-27T14:09:23.000Z - 5 months ago

Maxim starts Polaryx at Buy, sees PLX-200 as differentiated

Polaryx commits to patients with rare pediatric lysosomal storage disorders

2026-02-27T13:43:18.000Z - 5 months ago

Polaryx commits to patients with rare pediatric lysosomal storage disorders

Polaryx Therapeutics Marks Rare Disease Day, Reaffirming Commitment to Patients with Rare Pediatric Lysosomal Storage Disorders

Feb 27, 2026, 8:30 AM EST - 5 months ago

Polaryx Therapeutics Marks Rare Disease Day, Reaffirming Commitment to Patients with Rare Pediatric Lysosomal Storage Disorders

Polaryx initiated with a Buy at Maxim

2026-02-27T13:15:01.000Z - 5 months ago

Polaryx initiated with a Buy at Maxim

Polaryx selects CRO for Soteria Phase 2 trial

2026-02-17T13:35:43.000Z - 6 months ago

Polaryx selects CRO for Soteria Phase 2 trial

Polaryx Therapeutics Selects Contract Research Organization for SOTERIA Phase 2 Basket Trial

Feb 17, 2026, 8:30 AM EST - 6 months ago

Polaryx Therapeutics Selects Contract Research Organization for SOTERIA Phase 2 Basket Trial

Polaryx announces pre-clinical data related to Soteria

2026-02-10T13:35:26.000Z - 6 months ago

Polaryx announces pre-clinical data related to Soteria

Polaryx Announces Key Pre-Clinical Data Related to SOTERIA at the 22nd Annual WORLDSymposium™

Feb 10, 2026, 8:30 AM EST - 6 months ago

Polaryx Announces Key Pre-Clinical Data Related to SOTERIA at the 22nd Annual WORLDSymposium™

Polaryx Therapeutics, Inc. trading resumes

2026-02-06T15:20:14.000Z - 6 months ago

Polaryx Therapeutics, Inc. trading resumes

Polaryx Therapeutics, Inc. trading halted, volatility trading pause

2026-02-06T15:10:13.000Z - 6 months ago

Polaryx Therapeutics, Inc. trading halted, volatility trading pause

Polaryx Therapeutics, Inc. trading resumes

2026-02-05T20:35:14.000Z - 6 months ago

Polaryx Therapeutics, Inc. trading resumes

Polaryx Therapeutics, Inc. trading halted, volatility trading pause

2026-02-05T20:30:16.000Z - 6 months ago

Polaryx Therapeutics, Inc. trading halted, volatility trading pause

Polaryx appoints Mitchel Berger, Francis Braun, Charles Ryan to board

2026-02-05T13:45:44.000Z - 6 months ago

Polaryx appoints Mitchel Berger, Francis Braun, Charles Ryan to board

Polaryx Therapeutics Welcomes New Members of the Board of Directors

Feb 5, 2026, 8:30 AM EST - 6 months ago

Polaryx Therapeutics Welcomes New Members of the Board of Directors

Polaryx Therapeutics, Inc. trading resumes

2026-02-04T15:05:33.000Z - 6 months ago

Polaryx Therapeutics, Inc. trading resumes

Polaryx Therapeutics, Inc. trading halted, volatility trading pause

2026-02-04T14:55:29.000Z - 6 months ago

Polaryx Therapeutics, Inc. trading halted, volatility trading pause

Polaryx Therapeutics, Inc. trading resumes

2026-02-03T15:20:11.000Z - 6 months ago

Polaryx Therapeutics, Inc. trading resumes

Polaryx Therapeutics, Inc. trading halted, volatility trading pause

2026-02-03T15:10:27.000Z - 6 months ago

Polaryx Therapeutics, Inc. trading halted, volatility trading pause

Polaryx to Present Late-Breaker Data Related to SOTERIA at the 22nd Annual WORLDSymposium™ as Company Prepares for SOTERIA Trial Launch

Feb 3, 2026, 8:30 AM EST - 6 months ago

Polaryx to Present Late-Breaker Data Related to SOTERIA at the 22nd Annual WORLDSymposium™ as Company Prepares for SOTERIA Trial Launch

Polaryx Therapeutics Announces Direct Listing on Nasdaq; Shares to Begin Trading Under the Symbol “PLYX”

Feb 2, 2026, 8:30 AM EST - 6 months ago

Polaryx Therapeutics Announces Direct Listing on Nasdaq; Shares to Begin Trading Under the Symbol “PLYX”

Polaryx Therapeutics Announces Approval to List Common Stock on Nasdaq

Jan 30, 2026, 8:00 AM EST - 6 months ago

Polaryx Therapeutics Announces Approval to List Common Stock on Nasdaq

Paraplego
Paraplego Aug. 4 at 3:52 PM
$NWBO is waiting game and im fine with it while im waiting im investing in $PLYX 14th Avgust is close for News and some small gains
0 · Reply
lew0303
lew0303 Jul. 31 at 1:47 PM
$PLYX still going up?
0 · Reply
z____b1
z____b1 Jul. 31 at 1:18 PM
$PLYX Not Bad!
0 · Reply
Bkaytradez
Bkaytradez Jul. 31 at 8:28 AM
$PLYX sub 2$ entry already paying off 💰
0 · Reply
Bkaytradez
Bkaytradez Jul. 31 at 8:28 AM
$PLYX 👀
0 · Reply
Lowkeyoptions
Lowkeyoptions Jul. 30 at 8:53 PM
$PLYX offering closed on watch
0 · Reply
Yebego
Yebego Jul. 29 at 6:18 PM
$AMIX $GSUN $NCRA $PLYX $SPRC
0 · Reply
HustlerTV
HustlerTV Jul. 29 at 6:09 PM
$PLYX short squeeze incoming $20 fair value… $NCRA $GSUN $SPRC $AMIX on watch for power hour
0 · Reply
StockfatherOG
StockfatherOG Jul. 29 at 6:08 PM
$PLYX golden biotech opportunity. Multiple $7 Price targets.
0 · Reply
Deelam
Deelam Jul. 28 at 3:34 AM
$PLYX Another initial coverage setting the PT at $7. https://uk.investing.com/news/stock-market-news/lucid-capital-initiates-polaryx-stock-with-buy-rating-on-rare-disease-therapy-potential-93CH-4789487
0 · Reply
MurrayK
MurrayK Jul. 27 at 3:27 PM
$PLYX Man, we bought a dud here. Will be another cash raise I’m sure before end of year. Was primed for a pump and dump which looks like the only thing that’ll save current investors. Otherwise we’ll likely be diluted out.
0 · Reply
focafoca99
focafoca99 Jul. 17 at 12:19 PM
$PLYX set its 2026 annual meeting for Sept. 10, to be held virtually.
0 · Reply
Deelam
Deelam Jul. 14 at 8:16 AM
$PLYX What the sweet jesus is happening? Since HCW's coverage it's sold off day after day after day. It's about to break through support under 2.
0 · Reply
MurrayK
MurrayK Jul. 10 at 1:55 PM
$PLYX XBI biotech index has skyrocket and at 5 year high. Almost all biotech pumping while this dog gets walked down to lows.
1 · Reply
Deelam
Deelam Jul. 9 at 8:09 PM
$PLYX H.C. Wainwright & Co. Initiates Coverage on PolaryxTherapeutics -- Price Target Set at $7.00 https://www.gurufocus.com/news/8951001/plyx-initiates-coverage-on-polaryx-therapeutics-price-target-set-at-700
0 · Reply
tradehulk
tradehulk Jul. 7 at 4:07 PM
$PLYX 🚨 $CHAI hires new CFO, previously at $RGNT, $GLMD, and $PLRZ. 💥
0 · Reply
tradehulk
tradehulk Jul. 7 at 4:03 PM
$PLYX 🚨 $CHAI hires new CFO, previously at $RGNT, $GLMD, and $PLRZ. 💥
0 · Reply
Deelam
Deelam Jun. 30 at 5:56 PM
$PLYX Anyone know why we're moving today? News about to pop?
2 · Reply
jucebot
jucebot Jun. 11 at 9:18 PM
FJ opened a long position in $PLYX @ $2.45 $GELS $KZIA $MSOS $OCG
0 · Reply
jucebot
jucebot Jun. 11 at 9:16 PM
FJ entered a long on $PLYX @ $2.45 $GELS $KZIA $MSOS $OCG
0 · Reply
jucebot
jucebot Jun. 11 at 9:14 PM
FJ entered a long on $PLYX @ $2.45 $GELS $KZIA $MSOS $OCG
0 · Reply
jucebot
jucebot Jun. 11 at 8:53 PM
FJ loaded up a long in $PLYX @ $2.45 $KZIA $MSOS $OCG
0 · Reply